ERLYSIGN Achieves CDSCO Approval for Large-Scale Clinical Trials for Oral Cancer Detection Technology

ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory agency CDSCO for its active salivary biomarker study designed for early cancer detection

Piramal Group Arm Funds Rs 110 Crore in Biodeal Pharmaceuticals

The Piramal Group, a leading Global Business Conglomerate, declared a Rs 110-crore interest in Biodeal Pharmaceuticals. The contract improvement and assembling organization will send the investment mixed by Piramal Options for working on its...

World Health Day 2024 Marks CAHO's International Expansion

On the occasion of World Health Day 2024, CAHO (Consortium of Accredited Healthcare Organizations), a distinguished not-for-profit organization committed to advancing quality initiatives within Indian healthcare establishments, proudly announces...

Johnson & Johnson To Acquire Shockwave Medical For USD 13.1 Billion

Johnson and Johnson, a pharmaceutical industry firm, has declared a conclusive arrangement to acquire all outstanding Shockwave Medical, Inc. shares for $335.00 per share in real money. This transaction relates to a venture worth roughly $13.1...

India's Healthcare Industry Witnesses 12.59 Percent Growth in 2024-25

India's healthcare industry scene has changed, pushed by significant interests in framework improvement. The Union Health Ministry's allotment of Rs 90,658.63 crore in the interim Budget for 2024-2025 showcases a 12.59 percent hike, highlighting...

Bayer and Dr Reddy’s Ink Pact To Promote Heart Failure Drug in India

Dr. Reddy’s Laboratories Ltd, a leading multinational pharmaceutical company, has forayed into an alliance with Bayer to promote and distribute the heart failure drug Vericiguat brand throughout India. Dr. Reddy’s...

© 2024 India Pharma Outlook. All Rights Reserved.